Could Roivant Sciences Be a Multibagger Stock Soon
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Identify the best credit card for points and cash back. Tailor your rewards to fit your lifestyle and spending patterns.
28,408 articlesBiotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
What would it look like if a legendary duo concentrated nearly $80 billion into one stock? This thought-provoking pie...
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...